2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
3
Zollinger-Ellison Syndrome
2
Stomach Neoplasms
2
Gastroesophageal Reflux
2
Barrett Esophagus
2
Xerostomia
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Stomach Ulcer
1
Pseudomyxoma Peritonei
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia
1
Mucositis
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, B-Cell
1
Hemorrhage
1
Helicobacter Infections
1
Heartburn
1
Head and Neck Neoplasms
1
Gastritis, Atrophic
1
Esophagitis, Peptic
1
Endometrial Neoplasms
1
Carcinoma, Neuroendocrine
1
Carcinoid Tumor
1
Appendiceal Neoplasms
1
Interventions
Cyclophosphamide
17
ofatumumab
14
fludarabine
11
Rituximab
11
ibrutinib
10
fludarabine phosphate
9
acalabrutinib
7
Lenalidomide
6
Bendamustine Hydrochloride
6
venetoclax
5
obinutuzumab
5
Vincristine
4
Mesna
4
Melphalan
4
Immunotherapy, Adoptive
4
pirtobrutinib
3
Whole-Body Irradiation
3
Mycophenolic Acid
3
Chlorambucil
3
Bortezomib
3
Alemtuzumab
3
spebrutinib
2
navitoclax
2
idelalisib
2
Tacrolimus
2
Tablets
2
Stem Cell Transplantation
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
KW-2478
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, B-Cell
×
Lansoprazole
×
Clear all
NCT01279252
2019-01-25
CLEAR
King's College Hospital NHS Trust
Phase 2
Completed
71 enrolled